Next 10 |
home / stock / gnwsf / gnwsf news
With Record Turnout Majority of Votes Support Directors TORONTO, ON / ACCESSWIRE / June 30, 2021 / StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") is pleased to report that shareholders, voted in favour of the tabled resolutions, including the election of all nomi...
StageZero's Richmond, VA laboratory provides same-day test results and documentation required for travel to many international destinations RICHMOND, VA / ACCESSWIRE / June 2, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing d...
StageZero Life Sciences Ltd. (GNWSF) Q1 2021 Earnings Conference Call May 17, 2021 10:00 a.m. ET Company Participants James Howard-Tripp - Chairman & CEO Padman Vamadevan - Medical Director, Care Oncology Presentation Operator Good morning, everyone, and thank you for joining StageZero Li...
TORONTO, ON / ACCESSWIRE / May 5, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing dedicated to the early detection of multiple diseases through whole blood, today announced it will distribute via its partner Ichor Blood Services thr...
Stagezero Life Sciences (GNWSF): Q4 GAAP EPS of -C$0.02.Revenue of C$2.82MPress Release For further details see: Stagezero Life Sciences reports Q4 results
StageZero Life Sciences Ltd. detects early stage cancer and multiple disease states through blood examination screening tests. They also do COVID-19 testing. One in 5 men and one in 6 women worldwide develop cancer during their lifetime, with 9.6 million global deaths from cancer in 2...
Stagezero Life Sciences Ltd. (GNWSF): Q3 GAAP EPS of -$0.18.Revenue of $1.46M (+7200.0% Y/Y)Press Release For further details see: Stagezero Life Sciences Ltd. reports Q3 results
StageZero Life Sciences ([[GNWSF]]) announced marketed offering of ~6.41M units and a maximum of ~12.82M units for gross proceeds of ~C$5M-~C$10M.Each unit will be offered at a price of $0.78 and will be comprised of one common share of the company and one-half of one common share purchase wa...
StageZero Life Sciences Ltd. Announces Pricing of Public Offering Canada NewsWire TORONTO, Oct. 20, 2020 /NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION THROUGH U.S. NEWSWIRE SERVICES/ TORONTO , Oct. 20, 2020 /CNW/ - StageZero Life Sci...
Stagezero Life Sciences ( OTCPK:GNWSF ) : Q2 GAAP EPS of $0.00. More news on: StageZero Life Sciences Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Genenews Ltd New Company Name:
GNWSF Stock Symbol:
OTCMKTS Market:
With Record Turnout Majority of Votes Support Directors TORONTO, ON / ACCESSWIRE / June 30, 2021 / StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") is pleased to report that shareholders, voted in favour of the tabled resolutions, including the election of all nomi...
StageZero's Richmond, VA laboratory provides same-day test results and documentation required for travel to many international destinations RICHMOND, VA / ACCESSWIRE / June 2, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing d...
TORONTO, ON / ACCESSWIRE / May 5, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing dedicated to the early detection of multiple diseases through whole blood, today announced it will distribute via its partner Ichor Blood Services thr...